Bupivacaine
- Generic Name
- Bupivacaine
- Brand Names
- Exparel, Kenalog, Marbeta, Marcaine, Marcaine With Epinephrine, Marvona Suik, P-Care M, P-Care MG, P-care, Posimir, Readysharp Anesthetics Plus Ketorolac, Readysharp-A, Readysharp-p40, Readysharp-p80, Sensorcaine, Sensorcaine With Epinephrine, Vivacaine, Xaracoll, Exparel liposomal
- Drug Type
- Small Molecule
- Chemical Formula
- C18H28N2O
- CAS Number
- 38396-39-3
- Unique Ingredient Identifier
- Y8335394RO
- Background
Bupivacaine is a widely used local anesthetic agent.
- Indication
As an implant, bupivacaine is indicated in adults for placement into the surgical site to produce postsurgical analgesia for up to 24 hours following open inguinal hernia repair.
...
- Associated Conditions
- Acute Gouty Arthritis, Adrenocortical Insufficiency, Alopecia Areata (AA), Ankylosing Spondylitis (AS), Berylliosis, Bullous dermatitis herpetiformis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Dermatomyositis (DM), Discoid Lupus Erythematosus (DLE), Edema of the cerebrum, Epicondylitis, Hemolytic Anemia, Hypercalcemia caused by Cancer, Keloids Scars, Leukemias, Mycosis Fungoides (MF), Necrobiosis lipoidica diabeticorum, Ocular Inflammation, Ophthalmia, Sympathetic, Osteoarthritis (OA), Pain, Labor, Polymyositis, Postoperative pain, Psoriatic Arthritis, Psoriatic plaque, Pure Red Cell Aplasia, Regional Enteritis, Rheumatoid Arthritis, Secondary thrombocytopenia, Stevens-Johnson Syndrome, Synovitis, Systemic Lupus Erythematosus, Temporal Arteritis, Trichinosis, Tuberculous Meningitis, Ulcerative Colitis, Uveitis, Acute Bursitis, Acute Idiopathic Nephrotic Syndrome, Acute Lupus Erythematosus, Acute Multiple sclerosis, Acute Rheumatic heart disease, unspecified, Acute nonspecific tenosynovitis, Cystic tumors of aponeurosis, Cystic tumors of tendon, Disseminated Pulmonary Tuberculosis (TB), Exfoliative erythroderma, Inflammatory lesions of granuloma annulare, Inflammatory lesions of lichen planus, Inflammatory lesions of lichen simplex, Non-suppurative Thyroiditis, Permphigus, Severe Allergic Reactions
- Associated Therapies
- General Anesthesia, Local Anaesthesia therapy, Regional nerve block therapy
EXPAREL Infiltrated Into the TAP for Postoperative Analgesia in Unilateral Abdominal Hernia Repair
- First Posted Date
- 2013-02-28
- Last Posted Date
- 2021-03-08
- Lead Sponsor
- Pacira Pharmaceuticals, Inc
- Target Recruit Count
- 13
- Registration Number
- NCT01801124
- Locations
- 🇺🇸
Maimonides Medical Center, Brooklyn, New York, United States
To Compare lidocaine2%/Clonidine in Combination, With Bupivacaine 0.5 % Alone in Equal Volumes for Combined Sciatic-saphenous Nerve Block in Terms of Selectivity of Blockade
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-01-03
- Last Posted Date
- 2013-11-19
- Lead Sponsor
- Cork University Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT01759524
- Locations
- 🇮🇪
Cork University Hospital, Cork, Ireland
Dexamethasone and Block Duration in Upper Extremity
Not Applicable
Terminated
- Conditions
- Interventions
- First Posted Date
- 2012-12-27
- Last Posted Date
- 2019-05-14
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 5
- Registration Number
- NCT01756573
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Dexamethasone and Lower Extremity Block Duration
- First Posted Date
- 2012-12-27
- Last Posted Date
- 2017-06-27
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 4
- Registration Number
- NCT01756586
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Effect of Dexamethasone on Duration of Lower Extremity Blocks With Bupivacaine in Subjects Having ACL Repair
- First Posted Date
- 2012-12-27
- Last Posted Date
- 2019-05-14
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 2
- Registration Number
- NCT01756560
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Bupivacaine Versus Lidocaine Local Anesthesia
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-12-18
- Last Posted Date
- 2015-12-14
- Lead Sponsor
- University of British Columbia
- Target Recruit Count
- 135
- Registration Number
- NCT01751347
- Locations
- 🇨🇦
Vancouver General Hospital, Vancouver, British Columbia, Canada
Evaluation of a TAP Block Given During Laparoscopic Colorectal Surgery to Help Control Pain
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-11-22
- Last Posted Date
- 2022-11-03
- Lead Sponsor
- University Hospitals Cleveland Medical Center
- Target Recruit Count
- 79
- Registration Number
- NCT01731782
- Locations
- 🇺🇸
University Hospitals Case Medical Center, Cleveland, Ohio, United States
Use of the Tx360 Nasal Applicator in the Treatment of Chronic Migraine
- First Posted Date
- 2012-10-18
- Last Posted Date
- 2018-01-26
- Lead Sponsor
- Tian Medical Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT01709708
- Locations
- 🇺🇸
Clinvest/A Division of Banyan Group, Inc., Springfield, Missouri, United States
🇺🇸Michigan Head Pain & Neurological Institute, Ann Arbor, Michigan, United States
Injection of Local Anesthetic to Trocar Insertion Sites After Laparoscopy
- First Posted Date
- 2012-09-20
- Last Posted Date
- 2019-09-09
- Lead Sponsor
- Milton S. Hershey Medical Center
- Target Recruit Count
- 135
- Registration Number
- NCT01688596
- Locations
- 🇺🇸
Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
Comparison Between Ultrasound-guided and Landmark-guided Ankle Blocks
- Conditions
- Interventions
- First Posted Date
- 2012-09-13
- Last Posted Date
- 2012-09-13
- Lead Sponsor
- Hillel Yaffe Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT01684774
- Locations
- 🇮🇱
Hillel Yaffe Medical Center, Hadera, Israel
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath